Supernus Pharm
(SUPN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 113,056 | 110,993 | 57,284 | 91,221 | 13,944 |
| Depreciation Amortization | 18,333 | 17,246 | 7,619 | 2,919 | 1,669 |
| Income taxes - deferred | -5,832 | -4,167 | 21,224 | -41,787 | 0 |
| Accounts receivable | 15,751 | -35,856 | -24,059 | -15,619 | -8,638 |
| Other Working Capital | 801 | -4,734 | 23,710 | 8,448 | 12,173 |
| Other Operating Activity | 1,020 | 45,504 | 28,862 | 21,630 | 15,376 |
| Operating Cash Flow | $143,129 | $128,986 | $114,640 | $66,812 | $34,524 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -156,537 | -411,827 | -73,232 | -15,540 | -26,278 |
| PPE Investments | -1,387 | -844 | -2,029 | -1,603 | -2,104 |
| Purchase Sale Intangibles | N/A | N/A | N/A | -18,821 | -10,907 |
| Other Investing Activity | 0 | -809 | -11,154 | -18,821 | -10,907 |
| Investing Cash Flow | $-157,924 | $-413,480 | $-86,415 | $-35,964 | $-39,289 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 402,500 | 0 | N/A | N/A |
| Common Stock Issued | 3,928 | 11,582 | 5,681 | 2,052 | 1,867 |
| Other Financing Activity | 0 | -37,644 | 0 | 0 | 0 |
| Financing Cash Flow | $3,928 | $376,438 | $5,681 | $2,052 | $1,867 |
| Beginning Cash Position | 192,248 | 100,304 | 66,398 | 33,498 | 36,396 |
| End Cash Position | 181,381 | 192,248 | 100,304 | 66,398 | 33,498 |
| Net Cash Flow | $-10,867 | $91,944 | $33,906 | $32,900 | $-2,898 |
| Free Cash Flow | |||||
| Operating Cash Flow | 143,129 | 128,986 | 114,640 | 66,812 | 34,524 |
| Capital Expenditure | -1,387 | -844 | -2,029 | -1,603 | -2,104 |
| Free Cash Flow | 141,742 | 128,142 | 112,611 | 65,209 | 32,420 |